Literature DB >> 19270027

Understanding the relationship between age and thyroid cancer.

Megan R Haymart1.   

Abstract

Unique among malignancies, age is a key prognostic indicator for well-differentiated thyroid cancer. Patients aged <45 years can have the same degree of disease involvement and a distinctly different prognosis than those aged >45. Although the reason for the association between age and outcome is not entirely clear, it does imply that there is something intrinsic to either the cancer or the treatment that is age dependent. This article explores the characteristics of the normal thyroid and thyroid cancer that are age dependent. It then provides theories for the relationship between advanced age and poor prognosis, in addition to treatment options tailored to age at diagnosis.

Entities:  

Mesh:

Year:  2009        PMID: 19270027     DOI: 10.1634/theoncologist.2008-0194

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  44 in total

1.  An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Laura Y Wang; Jocelyn C Migliacci; Antoine Eskander; Michael J Campbell; Ahmad Aniss; Lilah Morris; Fernanda Vaisman; Rossana Corbo; Denise Momesso; Mario Vaisman; Andre Carvalho; Diana Learoyd; William D Leslie; Richard W Nason; Deborah Kuk; Volkert Wreesmann; Luc Morris; Frank L Palmer; Ian Ganly; Snehal G Patel; Bhuvanesh Singh; R Michael Tuttle; Ashok R Shaha; Mithat Gönen; K Alok Pathak; Wen T Shen; Mark Sywak; Luis Kowalski; Jeremy Freeman; Nancy Perrier; Jatin P Shah
Journal:  Thyroid       Date:  2016-02-25       Impact factor: 6.568

2.  Establishment and validation of a nomogram model for predicting the survival probability of differentiated thyroid carcinoma patients: a comparison with the eighth edition AJCC cancer staging system.

Authors:  Ruyi Zhang; Mei Xu; Xiangxiang Liu; Miao Wang; Qiang Jia; Shen Wang; Xiangqian Zheng; Xianghui He; Chao Huang; Yaguang Fan; Heng Wu; Ke Xu; Dihua Li; Zhaowei Meng
Journal:  Endocrine       Date:  2021-04-06       Impact factor: 3.633

Review 3.  Approach to and treatment of thyroid disorders in the elderly.

Authors:  Maria Papaleontiou; Megan R Haymart
Journal:  Med Clin North Am       Date:  2012-02-14       Impact factor: 5.456

4.  Predictive factors for lateral occult lymph node metastasis in papillary thyroid carcinoma.

Authors:  Vincent Patron; Martin Hitier; Cécile Bedfert; Alexandre Métreau; Audrey Dugué; Franck Jegoux
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-13       Impact factor: 2.503

Review 5.  Optimal differentiated thyroid cancer management in the elderly.

Authors:  Donald S A McLeod; Kelly Carruthers; Dev A S Kevat
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

6.  Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence.

Authors:  Sona Shah; Laura Boucai
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

7.  Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.

Authors:  Allen S Ho; Michael Luu; Cynthia Zalt; Luc G T Morris; Irene Chen; Michelle Melany; Nabilah Ali; Chrysanta Patio; Yufei Chen; Jon Mallen St-Clair; Glenn D Braunstein; Wendy L Sacks; Zachary S Zumsteg
Journal:  Thyroid       Date:  2019-09-24       Impact factor: 6.568

8.  Five-year longitudinal evaluation of quality of life in a cohort of patients with differentiated thyroid carcinoma.

Authors:  Massimo Giusti; Giulia Melle; Monica Fenocchio; Lorenzo Mortara; Francesca Cecoli; Valeria Caorsi; Diego Ferone; Francesco Minuto; Elda Rasore
Journal:  J Zhejiang Univ Sci B       Date:  2011-03       Impact factor: 3.066

9.  Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Deborah Kuk; Volkert Wreesmann; Luc Morris; Frank L Palmer; Ian Ganly; Snehal G Patel; Bhuvanesh Singh; R Michael Tuttle; Ashok R Shaha; Mithat Gönen; Jatin P Shah
Journal:  Ann Surg Oncol       Date:  2015-07-28       Impact factor: 5.344

10.  Relationship between lymphovascular invasion and clinicopathological features of papillary thyroid carcinoma.

Authors:  Atakan Sezer; Mehmet Celik; Buket Yilmaz Bulbul; Nuray Can; Ebru Tastekin; Semra Ayturk; Funda Ustun; Sibel Guldiken; Necdet Sut
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.